Identification of key gene signatures for the overall survival of ovarian cancer

BACKGROUND: The five-year overall survival (OS) of advanced-stage ovarian cancer remains nearly 25-35%, although several treatment strategies have evolved to get better outcomes. A considerable amount of heterogeneity and complexity has been seen in ovarian cancer. This study aimed to establish gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawar, Akash, Chowdhury, Oindrila Roy, Chauhan, Ruby, Talole, Sanjay, Bhattacharjee, Atanu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780391/
https://www.ncbi.nlm.nih.gov/pubmed/35057823
http://dx.doi.org/10.1186/s13048-022-00942-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780391/
https://www.ncbi.nlm.nih.gov/pubmed/35057823
http://dx.doi.org/10.1186/s13048-022-00942-0

Ejemplares similares